Stay updated on Neoadjuvant Immunotherapy Combination in Stage III Melanoma Clinical Trial

Sign up to get notified when there's something new on the Neoadjuvant Immunotherapy Combination in Stage III Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neoadjuvant Immunotherapy Combination in Stage III Melanoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    - Revision: v3.4.3 added; Revision: v3.4.2 removed.
    Difference
    0.1%
    Check dated 2026-03-11T17:18:23.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the government funding lapse notice and Revision: v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-11T10:15:30.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    A government funding lapse notice has been added at the top of the page with operating-status guidance. The page revision has been updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T06:32:55.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The updates are minor UI/metadata changes (Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0), along with corresponding deletions of older labels (Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T04:05:13.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Footer revision updated from v3.3.3 to v3.3.4 with no other content changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:57:25.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added a Locations section with Kentucky as a study site. Removed the Kentucky Locations entry and the HHS Vulnerability Disclosure link; revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T10:25:20.000Z thumbnail image

Stay in the know with updates to Neoadjuvant Immunotherapy Combination in Stage III Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neoadjuvant Immunotherapy Combination in Stage III Melanoma Clinical Trial page.